Home Page
Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Donate Now
Access Resources

MJFF Publications
6821 - 6830 of 9156 Results
Title
Year
  • Year
  • 2013
  • 2014
  • 2017
  • 2012
  • 2018
  • 2014
  • 2020
  • 2019
  • 2013
  • 2019
  • Disease-modifying therapies for Parkinson's disease
    2013
    Summary Details
    OPEN
    Title: Disease-modifying therapies for Parkinson's disease
    Author(s): Todd Sherer
    Journal Name: The Biomedical & Life Sciences Collection
    Publisher: Henry Stewart Talks
    Vol: 2013
    Issue #: 3
    Start Page: e1003178
    End Page: e1003178
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.69645/krxj9755
    Citation Count: 0
  • Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    2014
    Summary Details
    RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Author(s): Maurizio Facheris, Wai Kin D. Ko, Elsa Y. Pioli, Qin Li, Steve McGuire, Alison Urkowitz, Audrey Dufour, Erwan Bézard, Todd Sherer
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 82
    Issue #: 10_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016
    Citation Count: 0
  • Beliefs About Use of Complementary Health Approaches for Parkinson's Disease
    2017
    Summary Details
    OPEN
    Title: Beliefs About Use of Complementary Health Approaches for Parkinson's Disease
    Author(s): Ju Young Shin, Ryan T. Pohlig, Barbara Habermann
    Journal Name: Holistic Nursing Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 31
    Issue #: 5
    Start Page: 290
    End Page: 294
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950
    Citation Count: 0
  • P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    2012
    Summary Details
    RESTRICTED
    Title: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    Author(s): Larry Ereshefsky, Mark Frasier, Mark Yen, Stanford S. Jhee, Kenneth Marek, Peggy Taylor, Molly Hamilton Sherman, Chelsea Caspell, Christopher S. Coffey, Michael G. Schlossmacher, Todd Sherer
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 8
    Issue #: 4S_Part_3
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296
    Citation Count: 0
  • O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    2018
    Summary Details
    RESTRICTED
    Title: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    Author(s): Samantha J. Hutten, Brit Mollenhauer, F. DuBois Bowman, Daniel Drake, Jimmy Duong, Kaj Blennow, Veronika Corradini, Omar M. A. El‐Agnaf, Yi‐Ju Li, Jennifer Masucci, Peggy Taylor, Robert M. Umek, Jill Dunty, Christopher L. Smith, Erik Stoops, Hugo Vanderstichele, Adrien W. Schmid, Marc Moniatte, Jing Zhang, Niels Kruse, Hilal A. Lashuel, Charlotte E. Teunissen, Tanja Schubert, Kuldip D. Dave, Henrik Zetterberg
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 14
    Issue #: 7S_Part_11
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691
    Citation Count: 0
  • Fox Trial Finder, un nouvel outil pour la recherche clinique
    2014
    Summary Details
    RESTRICTED
    Title: Fox Trial Finder, un nouvel outil pour la recherche clinique
    Author(s): S. Villars, Leonardo Cappelletti, Włodzimierz Meissner
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Vol: 170
    Issue #:
    Start Page: A133
    End Page: A134
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360
    Citation Count: 0
  • Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease
    2020
    Summary Details
    OPEN
    Title: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease
    Author(s): Lana M. Chahine, Briana Edison, Sneha Mantri, Catherine Kopil, Connie Marras
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Vol: 7
    Issue #: 7
    Start Page: 879
    End Page: 880
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13021
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975
    Citation Count: 0
  • Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    2019
    Summary Details
    RESTRICTED
    Title: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    Author(s): Ruth B. Schneider, Shalini Anthwal, Elise Kayson, Larsson Omberg, Christopher G. Tarolli, Eric A. Macklin, Lauren Bataille, E. Ray Dorsey, Lara M. Mangravite, Michael A. Schwarzschild, Tanya Simuni
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 92
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011
    Citation Count: 0
  • No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    2013
    Summary Details
    RESTRICTED
    Title: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    Author(s): Christopher G. Goetz, Glenn T. Stebbins, Kathryn Chung, Robert A. Hauser, Janis M. Miyasaki, Anthony Nicholas, Werner Poewe, Klaus Seppi, Olivier Rascol, Mark Stacy, John G. Nutt, Caroline M. Tanner, Alison Urkowitz, Jean A. Jaglin, Siqi Ge
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 80
    Issue #: 7_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187
    Citation Count: 0
  • Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    2019
    Summary Details
    OPEN
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Author(s): Heather L. Benz, Brittany Caldwell, John P. Ruiz, Anindita Saha, Martin Ho, Stephanie Christopher, D. Bardot, Margaret Sheehan, Anne Donnelly, Lauren P. McLaughlin, Brennan Mange, Brett Hauber, Katrina Gwinn, Murray Sheldon
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Vol: 12
    Issue #: 2
    Start Page: e28
    End Page: e29
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.